School of Psychology, The University of Sydney, Australia.
Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Australia.
J Anxiety Disord. 2020 Dec;76:102309. doi: 10.1016/j.janxdis.2020.102309. Epub 2020 Sep 17.
Intolerance of uncertainty is a psychological vulnerability implicated in the development and maintenance of generalized anxiety disorder (GAD). The Intolerance of Uncertainty Scale-12 (IUS-12) is a widely used measure, however no studies have thoroughly tested the psychometric properties in a clinically diagnosed GAD sample. This study aimed to evaluate the factor structure, measurement properties and clinical utility of the IUS-12 in clinical and non-clinical samples. Participants were screened using the Anxiety Disorders Interview Schedule for DSM-IV to ascertain clinical (n = 136: principal diagnosis of GAD) or non-clinical status (n = 76). Confirmatory factor analysis determined that the bifactor type (two-factor testlet) model demonstrated significantly better fit in comparison to the unidimensional model for the clinical sample. The IUS-12 exhibited limited multidimensionality indicating that only the total score provides meaningful interpretation. The IUS-12 demonstrated good construct validity (with DASS-21, MCQ-30, and PSWQ), good internal consistency, as well as good test-retest reliability over 12-weeks. The IUS-12 demonstrated responsivity to treatment following cognitive behavioral therapy and mindfulness based psychological interventions. Receiver operating characteristic curve analysis indicated an optimal cut-off score of 28 for distinguishing individuals with GAD from non-clinical cases. Overall, the IUS-12 is a valid, reliable and clinically useful instrument for individuals with GAD.
不确定性容忍度是一种心理脆弱性,与广泛性焦虑症(GAD)的发展和维持有关。不确定性容忍量表-12 版(IUS-12)是一种广泛使用的测量工具,但尚无研究在临床诊断为 GAD 的样本中彻底测试其心理测量特性。本研究旨在评估 IUS-12 在临床和非临床样本中的因子结构、测量特性和临床实用性。使用 DSM-IV 焦虑障碍访谈表对参与者进行筛查,以确定临床(n=136:GAD 的主要诊断)或非临床状态(n=76)。验证性因子分析确定,与单维模型相比,双因素测验模型(二因素测验模型)在临床样本中具有更好的拟合度。IUS-12 表现出有限的多维性,表明只有总分提供有意义的解释。IUS-12 表现出良好的结构效度(与 DASS-21、MCQ-30 和 PSWQ 相关)、良好的内部一致性,以及在 12 周内的良好重测信度。IUS-12 表明在认知行为疗法和基于正念的心理干预后对治疗有反应。受试者工作特征曲线分析表明,区分 GAD 个体与非临床病例的最佳截断值为 28。总体而言,IUS-12 是一种有效、可靠且对 GAD 个体具有临床实用性的工具。